Statement from DPA New York State Director Melissa Moore on Gov. Cuomo 30-Day Amendments to Marijuana Legalization Bill
New York, NY - February 16, 2021 (Investorideas.com Newswire) This morning Governor Cuomo announced changes to his legalization proposal in a press release. The full bill text with the 30-day amendments has not yet been publicly released.
Statement from Melissa Moore, New York State Director of the Drug Policy Alliance and member of Start SMART NY Coalition (Sensible Marijuana Access through Regulated Trade):
"After advocates highlighted shortcomings in Gov. Cuomo's marijuana legalization plan, the Governor has announced amendments to his proposal. By reducing criminal penalties and allowing marijuana delivery services, the Governor has taken steps to address decades of disparate marijuana criminalization. There's no question this shift comes in response to powerful organizing for marijuana justice across the state and in the Legislature.
While these changes are a move in the right direction, they are not a substitute for the more comprehensive Marijuana Reform and Taxation Act (MRTA), which remains the gold standard reform bill in the Legislature. That must be the starting point as it has stronger equity and community reinvestment provisions and a more balanced governance structure for the Office of Cannabis Management than the Governor's proposal. We urge its swift passage to secure justice, jobs, equity, and true community investment for millions of New Yorkers."
About Drug Policy Alliance
The Drug Policy Alliance envisions a just society in which the use and regulation of drugs are grounded in science, compassion, health and human rights, in which people are no longer punished for what they put into their own bodies, and in which the fears, prejudices and punitive prohibitions of today are no more. Our mission is to advance those policies and attitudes that best reduce the harms of both drug use and drug prohibition, and to promote the autonomy of individuals over their minds and bodies. Learn more at drugpolicy.org.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Sign up for free stock news alerts at Investorideas.com